Positive Voice Of Kenya

  Kenya imports more than 70% of its pharmaceutical products, making the country highly vulnerable to global supply chain disruptions, foreign exchange fluctuations, and soaring drug prices . This dependency on imported medicines poses a significant challenge to healthcare affordability and access, particularly in low-income and rural communities. Amid these concerns, Kenya’s local pharmaceutical industry is gaining momentum. With rising demand for essential drugs, growing health needs, and supportive policy frameworks, domestic production is now seen as a critical pillar of healthcare resilience . At the center of this transformation is Jayesh Saini , founder of Dinlas Pharma , a company that has rapidly scaled up its manufacturing capacity to meet Kenya’s growing pharmaceutical demand. This case study examines the status of local drug manufacturing , Kenya’s regulatory and infrastructure challenges , and whether the country is positioned to reduce its reliance on imports through ...

  Africa’s healthcare systems are undergoing a transformation, driven not only by government initiatives but increasingly by private sector investments that are filling critical gaps in infrastructure, service delivery, and innovation. As the continent’s population grows and healthcare demands rise, private capital has become a vital force in expanding access to quality, affordable medical care. In countries like Kenya, this shift is clearly visible. Entrepreneurs and healthcare investors are building modern hospitals, manufacturing essential medicines locally, and integrating digital solutions —all while complementing public health goals. At the center of this transformation is Jayesh Saini , founder of Lifecare Hospitals, Bliss Healthcare, and Dinlas Pharma , whose investment-led healthcare model exemplifies how private capital can create scalable, inclusive, and sustainable healthcare systems. This article explores how private sector investments are revolutionizing access to c...